These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36253284)

  • 1. Effectiveness of the SUGAR intervention on hypoglycaemia in elderly patients with type 2 diabetes: A pragmatic randomised controlled trial.
    Almomani HY; Pascual CR; Grassby P; Ahmadi K
    Res Social Adm Pharm; 2023 Feb; 19(2):322-331. PubMed ID: 36253284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised controlled trial of pharmacist-led patient counselling in controlling hypoglycaemic attacks in older adults with type 2 diabetes mellitus (ROSE-ADAM): A study protocol of the SUGAR intervention.
    Almomani HY; Pascual CR; Al-Azzam SI; Ahmadi K
    Res Social Adm Pharm; 2021 May; 17(5):885-893. PubMed ID: 32763086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial.
    Bosi E; Choudhary P; de Valk HW; Lablanche S; Castañeda J; de Portu S; Da Silva J; Ré R; Vorrink-de Groot L; Shin J; Kaufman FR; Cohen O;
    Lancet Diabetes Endocrinol; 2019 Jun; 7(6):462-472. PubMed ID: 31047902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of flash glucose monitoring on hypoglycaemia in adults with type 1 diabetes managed with multiple daily injection therapy: a pre-specified subgroup analysis of the IMPACT randomised controlled trial.
    Oskarsson P; Antuna R; Geelhoed-Duijvestijn P; Krӧger J; Weitgasser R; Bolinder J
    Diabetologia; 2018 Mar; 61(3):539-550. PubMed ID: 29273897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial.
    Heinemann L; Freckmann G; Ehrmann D; Faber-Heinemann G; Guerra S; Waldenmaier D; Hermanns N
    Lancet; 2018 Apr; 391(10128):1367-1377. PubMed ID: 29459019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pen-administered low-dose dasiglucagon vs usual care for prevention and treatment of non-severe hypoglycaemia in people with type 1 diabetes during free-living conditions: a Phase II, randomised, open-label, two-period crossover trial.
    Laugesen C; Ranjan AG; Schmidt S; Nørgaard K
    Diabetologia; 2023 Jul; 66(7):1208-1217. PubMed ID: 37037948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoglycaemia Among Insulin-Treated Patients with Diabetes: Evaluation of the United Arab Emirates cohort of the International Operations-Hypoglycaemia Assessment Tool study.
    Abusnana S; Beshyah SA; Al-Mutawa N; Tahhan R; Jallo M; Arora R; Aly H; Singhal S
    Sultan Qaboos Univ Med J; 2018 Nov; 18(4):e447-e454. PubMed ID: 30988962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced severe hypoglycaemia in Type 2 diabetic patients aged 80 years or older.
    Greco D; Angileri G
    Diabetes Nutr Metab; 2004 Feb; 17(1):23-6. PubMed ID: 15163121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HypoAware-a brief and partly web-based psycho-educational group intervention for adults with type 1 and insulin-treated type 2 diabetes and problematic hypoglycaemia: design of a cost-effectiveness randomised controlled trial.
    Rondags SM; de Wit M; van Tulder MW; Diamant M; Snoek FJ
    BMC Endocr Disord; 2015 Aug; 15():43. PubMed ID: 26292674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial.
    Bolinder J; Antuna R; Geelhoed-Duijvestijn P; Kröger J; Weitgasser R
    Lancet; 2016 Nov; 388(10057):2254-2263. PubMed ID: 27634581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HypoAware: development and pilot study of a brief and partly web-based psychoeducational group intervention for adults with Type 1 and insulin-treated Type 2 diabetes and problematic hypoglycaemia.
    Rondags SM; de Wit M; Snoek FJ
    Diabet Med; 2016 Feb; 33(2):184-91. PubMed ID: 26234919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elderly patients with diabetes experience a lower rate of nocturnal hypoglycaemia with insulin degludec than with insulin glargine: a meta-analysis of phase IIIa trials.
    Sorli C; Warren M; Oyer D; Mersebach H; Johansen T; Gough SC
    Drugs Aging; 2013 Dec; 30(12):1009-18. PubMed ID: 24170235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.
    Semlitsch T; Engler J; Siebenhofer A; Jeitler K; Berghold A; Horvath K
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005613. PubMed ID: 33166419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of insulin analogues on risk of severe hypoglycaemia in patients with type 1 diabetes prone to recurrent severe hypoglycaemia (HypoAna trial): a prospective, randomised, open-label, blinded-endpoint crossover trial.
    Pedersen-Bjergaard U; Kristensen PL; Beck-Nielsen H; Nørgaard K; Perrild H; Christiansen JS; Jensen T; Hougaard P; Parving HH; Thorsteinsson B; Tarnow L
    Lancet Diabetes Endocrinol; 2014 Jul; 2(7):553-61. PubMed ID: 24794703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin during pregnancy, labour and delivery.
    de Valk HW; Visser GH
    Best Pract Res Clin Obstet Gynaecol; 2011 Feb; 25(1):65-76. PubMed ID: 21186142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing the management of hypoglycaemia in individuals with type 2 diabetes: A randomized crossover comparison of a weight-based protocol compared with two fixed-dose glucose regimens.
    Krebs JD; Weatherall M; Corley B; Wiltshire E; McTavish L
    Diabetes Obes Metab; 2018 May; 20(5):1256-1261. PubMed ID: 29359848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial.
    van Beers CA; DeVries JH; Kleijer SJ; Smits MM; Geelhoed-Duijvestijn PH; Kramer MH; Diamant M; Snoek FJ; Serné EH
    Lancet Diabetes Endocrinol; 2016 Nov; 4(11):893-902. PubMed ID: 27641781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of hypoglycaemia with insulin degludec versus insulin glargine U300 in insulin-treated patients with type 2 diabetes: the randomised, head-to-head CONCLUDE trial.
    Philis-Tsimikas A; Klonoff DC; Khunti K; Bajaj HS; Leiter LA; Hansen MV; Troelsen LN; Ladelund S; Heller S; Pieber TR;
    Diabetologia; 2020 Apr; 63(4):698-710. PubMed ID: 31984443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoglycaemia in the over 75s: Understanding the predisposing factors in type 2 diabetes (T2DM).
    Heald AH; Anderson SG; Cortes GJ; Cholokova V; Narajos M; Khan A; Donnahey G; Livingston M
    Prim Care Diabetes; 2018 Apr; 12(2):133-138. PubMed ID: 28941578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Incidence of severe hypoglycemia in relation to metabolic control and patient knowledge].
    Ratzmann KP; Schimke E
    Med Klin (Munich); 1995 Oct; 90(10):557-61. PubMed ID: 7500918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.